Navigation Links
Cystic Fibrosis Treatment May Cause Hearing Loss
Date:7/2/2009

Ear evaluation urged for youngsters taking common antibacterial medication

THURSDAY, July 2 (HealthDay News) -- A common antibacterial treatment for cystic fibrosis can cause sensorineural hearing loss, finds a new study.

Researchers reviewed the medical records of 50 cystic fibrosis patients treated over a 13-year period at Children's Hospital Boston and found that seven (14 percent) of them suffered from sensorineural hearing loss. Of those seven patients, 43 percent had received more than 10 courses of aminoglycosides intravenously.

Patients who underwent more than five treatments with nasal irrigation of aminoglycosides were also at risk for sensorineural hearing loss, the study found.

Pulmonary and sinonasal infections are common in cystic fibrosis patients. Because of their potency against bacteria, aminoglycosides are often given to cystic fibrosis patients, even though the treatments are known to cause side effects such as hair cell loss, which leads to hearing loss, according to information in a news release from the American Academy of Otolaryngology -- Head and Neck Surgery.

Cystic fibrosis patients should have regular hearing tests that specifically assess sensorineural hearing loss, especially when patients have undergone repeated courses of systemic or intranasal aminoglycoside treatments, the researchers concluded.

The study appears in the July issue of the journal Otolaryngology--Head and Neck Surgery.

More information

The Cystic Fibrosis Foundation has more about cystic fibrosis.



-- Robert Preidt



SOURCE: American Academy of Otolaryngology -- Head and Neck Surgery, news release, July 1, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Polycystic ovarian syndrome: New light on its causes and its effect on brothers
2. Women with cystic fibrosis can have safe and successful fertility treatment
3. KePRO Employees Make "Great Strides" Towards Cure for Cystic Fibrosis
4. iUniverse Hosts Canadian Storytellers, Cystic Fibrosis Awareness Advocate for BookExpo America 2009 Book Signings
5. State Fair Meadowlands Teams Up & Goes Trucking For Cystic Fibrosis Foundation
6. New Spray Could Benefit Cystic Fibrosis Patients
7. Sodium channel blocker shows promise as a potential treatment for cystic fibrosis
8. Cystic Fibrosis Foundation Rings Bell to Close New York Stock Exchange
9. Cystic Fibrosis Foundation Launches GREAT STRIDES Walks Nationwide at 600 Locations
10. CWs 7th Heaven Actress Mackenzie Rosman to Visit Birmingham Area High School to Honor Cystic Fibrosis Foundation Fundraising
11. Quest Diagnostics Discovers New Genetic Mutations Affecting Cystic Fibrosis Screening
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cystic Fibrosis Treatment May Cause Hearing Loss
(Date:7/26/2014)... According to the Metabolic Enhancement Training program ... bodybuilding program that helps men lose body fat and ... The program also instructs men how to melt fat ... reveals in its review that this program includes a ... get ripped and jacked at the same time. Vkool ...
(Date:7/26/2014)... July 26, 2014 As the ... the true vision of Xoçai is ... its exclusive and healthy chocolate products. One such ... of cacao, açaí berries and blueberries, an ingredient ... high-antioxidant blend is utilized in all of Xoçai ...
(Date:7/25/2014)... Ireland (PRWEB) July 26, 2014 ... quality legal help to people who have suffered ... the launch of both their new company, and ... article on the new website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims ... law. The focus of the company is always ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 In recent years, ... and eager to reverse the symptoms associated with age-related testosterone ... media at large, a new case study from ... benefits of testosterone therapy using bioidentical hormones. , The ... father from Seattle who found himself beginning to feel the ...
(Date:7/25/2014)... A federal judge has denied defense ... Pinnacle hip lawsuits ( http://www.depuypinnacle-lawsuit.com/ ) selected as ... go before a jury on September 1, 2014, Bernstein ... 18th, U.S. District Judge Ed Kinkeade of the Northern ... may proceed to trial against Johnson & Johnson, the ...
Breaking Medicine News(10 mins):Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4
... available at www.urac.org/bestpractices WASHINGTON, Feb. 13 ... Practices in Health Care Consumer Empowerment and Protection Conference ... In addition to Ian Morrison,s opening keynote address ... for Value for All Americans , and Lee Woodruff,s ...
... Medical Inc. (NYSE: SMA ), a leading independent ... other medical markets, announced today that Brian S. Moore, President ... President and Chief Financial Officer, are scheduled to present at ... Nevada, Las Vegas on Tuesday, February 24, 2009 at ...
... 13 Micromet, Inc. (Nasdaq: MITI ), today announced that ... Annual Orange County Growth Stock Conference at the Ritz-Carlton Laguna Niguel on ... Annual Orange County Growth Stock Conference, Date: ... Pacific Time, Place: The Ritz-Carlton Laguna Niguel, ...
... Feb. 13 /PRNewswire-Asia/ -- The Hong Kong Sanatorium ... team had,successfully performed a large number of cases ... the application of computer-assisted,navigation system since its first ... hospital in Hong Kong which has acquired the ...
... "number sense" appear to be part of the shared ... language to explain abstractions that apparently takes human math ... an assistant professor of psychology and neuroscience at Duke ... monkeys think about numbers without using language. She,s looking ...
... SAVANNAH, Ga., Feb. 13 Founders Club will donate $5 ... the Mammography Fund at St. Joseph,s/Candler. "The Mammography Fund ... crucial in the fight against cancer," Jeff Andrews, CEO of ... be sold at Edwin Watts Golf stores and specialty golf ...
Cached Medicine News:Health News:URAC Announces Agenda for 2009 Best Practices in Health Care Consumer Empowerment and Protection Conference 2Health News:URAC Announces Agenda for 2009 Best Practices in Health Care Consumer Empowerment and Protection Conference 3Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 2Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 3Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 4Health News:Navigation System Significantly Improves the Surgical Accuracy of Total Knee Replacement for Arthritis Patients 2Health News:Navigation System Significantly Improves the Surgical Accuracy of Total Knee Replacement for Arthritis Patients 3Health News:Navigation System Significantly Improves the Surgical Accuracy of Total Knee Replacement for Arthritis Patients 4Health News:Pre-verbal number sense common to monkeys, babies, college kids 2Health News:Founders Club Proudly Supports the St. Joseph's/Candler Mammography Fund 2
(Date:7/25/2014)... Laboratories, Inc. (NASDAQ: IDXX ) today reported ... 11% versus the prior year period to $390 million. ... of 2014 versus the prior year period was 9%, ... . Earnings per diluted share ("EPS") for the quarter ... year period to $1.10."In the second quarter, we continued ...
(Date:7/25/2014)... CHICAGO, Ill., July 25, 2014 NOT ... DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE ... LAWS OR REGULATIONS OF SUCH JURISDICTION AbbVie (NYSE: ... ended June 30, 2014. "This was another ... earnings per share above our original guidance and announced plans ...
(Date:7/24/2014)... OVERLAND PARK, Kan. , July 24, 2014 ... licensing of two compounds that will be added ... agreement with Australian-based CIMTECH Pty Ltd, a biotechnology ... and PAR 122 have shown promise in bone ... a license to develop the compounds for the ...
Breaking Medicine Technology:IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33IDEXX Laboratories Announces Second Quarter Results 34AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3
... March 19, 2012 Novartis Pharmaceuticals Corporation today ... 75 mcg is now available in the US ... is indicated for the long-term maintenance bronchodilator treatment ... obstructive pulmonary disease (COPD), including chronic bronchitis and/or ...
... Incorporated (Nasdaq: ARAY ), the premier radiation ... 2012 Industry Excellence Award by Microsoft® as part of the ... be honored at Convergence 2012 , the premier Microsoft ... Texas. The 2012 Customer Excellence Awards, which are ...
Cached Medicine Technology:Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 2Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 3Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 4Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 5Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 6Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 7Accuray Receives Microsoft Dynamics® Customer Excellence Award 2Accuray Receives Microsoft Dynamics® Customer Excellence Award 3Accuray Receives Microsoft Dynamics® Customer Excellence Award 4
ARION is a long-pulsed alexandrite laser system with a wavelength of 755 nm...
... to connect an infusion ... pump, and then to ... order to conduct urodynamics ... Laborie Medical Technologies infusion ...
Used for suprapubic monitoring of bladder pressures. Suprapubic urodynamic studies avoid the effects of urethral catheterization and eliminate the need for a double bladder puncture. Supplied sterile...
... Triage® Cardiac Panel is a ... rapid quantitative determination of CK-MB, ... ethylenediaminetetraacetic acid (EDTA) whole blood ... is used as an aid ...
Medicine Products: